Hasan Bayındır

Dr. Hasan Bayındır

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
ZMZülfikar Memis
Zülfikar Memis
EGErdem Gürkaş
Erdem Gürkaş
AÖAtilla Özcan Özdemir
Atilla Özcan Özdemir
Bilgehan Atılgan AcarBilgehan Atılgan Acar
Bilgehan Atılgan Acar
MÖMuhammed Nur Ögün
Muhammed Nur Ögün
TATalip Asil
Talip Asil
Background: The prognostic value of the neutrophil–lymphocyte ratio (NLR) in ischemic stroke remains debated due to cohort variability and treatment heterogeneity across studies. This study evaluates the relationship between admission NLR, stroke severity and 90-day outcomes in patients with anterior circulation large vessel occlusion (LVO) undergoing early, successful revascularization. Methods: A retrospective multicenter study was conducted with 1082 patients treated with mechanical thrombectomy for acute ischemic stroke. The relationship between admission NLR, baseline National Institutes of Health Stroke Scale (NIHSS), 24 h NIHSS and 90-day modified Rankin Scale (mRS) outcomes was analyzed using logistic regression. Results: Admission NLR correlated weakly but significantly with both baseline (p = 0.018) and 24 h (p = 0.005) NIHSS scores, reflecting stroke severity. However, multivariate analysis showed that higher 24 h NIHSS scores (OR 0.831, p = 0.000) and prolonged puncture-to-recanalization times (OR 0.981, p = 0.000) were independent predictors of poor 90-day outcomes, whereas NLR was not (p = 0.557). Conclusions: Admission NLR is associated with stroke severity but does not independently predict clinical outcomes at 90 days in patients achieving early and successful revascularization. These findings underscore the critical role of inflammation in the acute phase of stroke but suggest that its prognostic value for long-term outcomes is limited in this context.

3 June 2024 in Balkan Medical Journal
Verified
Journal Article
Open access
SKSumeyye Koc
Sumeyye Koc
SŞSedat Şen
Sedat Şen
YTYüksel Terzi
Yüksel Terzi
FKFerah Kızılay
Ferah Kızılay
SDSerkan Demir
Serkan Demir
MTMurat Terzi
Murat Terzi
Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and demographic features atypical for multiple sclerosis (MS) with optic neuritis and myelitis also demonstrate antibodies against aquaporin-4 and anti-MOG-IgG. However, data on the diagnosis, treatment, follow-up, and prognosis in patients with anti-MOG-IgG are limited. To evaluate the clinical, radiological, and demographic characteristics of patients with anti-MOG-IgG. Multicenter, retrospective, observational study. Patients with blood samples demonstrating anti-MOG-IgG that had been evaluated at the Neuroimmunology laboratory at Ondokuz Mayıs University's Faculty of Medicine were included in the study. Of the 104 patients with anti-MOG-IgG, 56.7% were women and 43.3% were men. Approximately 2.4% of the patients were diagnosed with MS, 15.8% with acute disseminated encephalomyelitis (ADEM), 39.4% with NMOSD, 31.3% with isolated optic neuritis, and 11.1% with isolated myelitis. Approximately 53.1% of patients with spinal involvement at clinical onset demonstrated a clinical course of NMOSD. Thereafter, 8.8% of these patients demonstrated a clinical course similar to MS and ADEM, and 28.1% demonstrated a clinical course of isolated myelitis. The response to acute attack treatment was lower and the disability was higher in patients aged > 40 years than patients aged < 40 years at clinical onset. Oligoclonal band was detected in 15.5% of the patients. For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG.

1 January 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EUESRA DEMIR UNAL
ESRA DEMIR UNAL
HBHesna Bektas
Hesna Bektas
HBHasan Bayındır
Hasan Bayındır
OKOguzhan Kursun
Oguzhan Kursun
Background/aim: Acute ischemic stroke (AIS) is characterized as a neurological deficit owing to an acute focal damage to the brain by cerebral infarction. A collateral score is the most significant factor evaluating the prognosis of AIS, its relationship with demographic data, serum biochemical parameters, and clinical disability in this field. Materials and methods: We conducted a single-center retrospective study with 100 patients with AIS within the first 6 h of ischemic stroke. Data for consecutive AIS patients were collected from February 2019 to May 2020. The collateral score was assessed by using developed scoring systems defined by Maas et al. The correlations between collateral score and demographic data, biochemical parameters, NIHSS scores (National Institutes of Health Stroke Scale), mRS (modified Rankin scale) scores were recorded. Results: The research was performed in 100 patients (median age, 71.55 +/- 11.46 years), and there was a statistically significant difference between elevated erythrocyte distribution width (RDW) and Maas collateral score (insular cortex) (p = 0.024) and lymphocyte/ Conclusion: In patients with acute MCA M1 occlusion, our analysis found a significant association between elevated RDW, low LMO parameters, and collateral score. We assume that, in terms of simple and quick usability in acute stroke prognosis, these parameters are useful and functional as a new biomarker.

19 November 2025 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
PDF file
EÇEsra Çıvgın
Esra Çıvgın
HBHasan Bayındır
Hasan Bayındır
Analysis of the baseline multiphase computed tomographic angiography findings to predict clinical outcomes in patients with middle cerebral artery M1 occlusion treated with mechanical thrombectomy - Diagnostic and Interventional Radiology

25 December 2020 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PDF file
HBHasan Bayındır
Hasan Bayındır
SKSunay Sibel Karayol
Sunay Sibel Karayol
HAHalil Ay
Halil Ay
Amaç: Bir yıl içerisinde iskemik inme tanısı ile nöroloji kliniğine başvuran 379 hastanın, radyolojik görüntülerini retrospektif olarak inceleyerek arkus aorta tiplerinin ve varyasyonlarının belirlenmesi, aorta tiplerinin sıklığının tespiti ve iskemik inmenin lokalizasyonu ile olan ilişkilerini araştırmaktır. Materyal ve metod: Şubat 2017-2018 tarihleri arasında nöroloji kliniğine iskemik inme tanısı ile başvuran 379 hasta retrospektif olarak değerlendirildi. Beyin manyetik rezonans görüntüleri (MRG), beyin bilgisayarlı tomografi (BT) ve karotis vertebral BT anjiografileri incelendi. Arkus aorta tipleri, varyasyonları, sıklığı, iskemik inmenin lokalizasyonu ile olan ilişkileri belirlendi. Bulgular: İskemik inme ile takip edilen ve karotis vertebral BT angiografi çekilen toplam 379 hastanın 219’u (%57.8) erkek, 160’ı (%42.2) kadın hastaydı. 288 hastada Tip1, 80 hastada Tip2 ve 11 hastada Tip3 arkus aorta mevcuttu. Çalışmaya katılan hastalardan 220’si ön sistem kaynaklı enfarkta, 159’u ise arka sistem kaynaklı enfarkta sahipti. Ön sistem enfaktı en çok %73,8 olarak Tip2 hastalarında vardı. Ön-arka ve sağ-sol dolaşım ayrımına göre yapılan değerlendirmede Tip1 arkuslu hastanın %30,9’unda, Tip2 arkuslu hastanın %61,2’sinde, Tip3 arkuslu hastanın %63,6’ünde sol-ön sistem kaynaklı enfarkt tespit edildi. Sonuç: Tüm iskemik inmelerde ön sistem sirkülasyonu kaynaklı enfarktlar daha sıktır. Arkus aorta tiplendirmesinde ise en sık Tip1 tespit edilmiştir. Ön sistem kaynaklı infaktların en sık Tip2 arkus aortada ve sol taraflı olduğu, arka sistem kaynaklı enfarktların ise daha sık Tip1 arkus aortalı hastalarda olduğu ve bu enfarktların da sağ arka sistem dolaşımda daha belirgin olarak izlendiği göze çarpmıştır.Anahtar Kelimeler: Aortik ark, Aort tipleri, Arkus varyasyonları, İskemik inme

18 August 2026 in Turkish Journal of Cerebrovascular Diseases
Verified
Journal Article
Open access
PDF file
HBHasan Bayındır
Hasan Bayındır
AAArlinda Abazaj
Arlinda Abazaj
KEKjanda Elpenoria
Kjanda Elpenoria
KDKlaudio Disha
Klaudio Disha
Objective: Subclavian steal syndrome (SSS) is a hemodynamic disorder caused by proximal subclavian artery stenosis, most commonly due to atherosclerosis, resulting in retrograde vertebrobasilar blood flow and impaired cerebral perfusion. This condition may present with neurological symptoms such as dizziness and syncope, as well as ischemic symptoms in the affected upper extremity. In this case report, we aim to highlight the pathophysiology, clinical features, current diagnostic modalities and treatment options of SSS in light of the literature, accompanied by a case treated with an endovascular intervention. Case Presentation: We report a case of 63-year-old patient with symptomatic severe subclavian artery stenosis and SSS who was successfully treated with endovascular subclavian stent placement. The patient with complaints of headache, intermittent dizziness, and numbness and pain in the left arm. Blood pressure measured on the right arm was 160/88 mmHg, whereas on the left arm it was 100/51 mmHg. An atherosclerotic plaque causing significant stenosis in the left subclavian artery. A balloon-expandable stent was deployed with balloon angioplasty at 8–10 atm pressure within the stenotic segment. The patient’s symptoms resolved completely, and the SSS was successfully treated. Conclusions: İn this case report a review of the current literature was also performed to evaluate the pathophysiology, clinical presentation, diagnostic modalities and treatment strategies for SSS. Subclavian steal syndrome’s endovascular therapy, including balloon angioplasty and stent implantation, is associated with lower morbidity compared to surgical intervention and is currently considered the first-line treatment.